Paper II
2022 July (Supplementary) (2019 Scheme) · 100 marks · 180 min

Question

Discuss Hepatitis B infection under the following headings:- (

  • (a) Clinical features ( 5 mark(s)
  • (b) Gross and microscopic changes in liver ( 5 mark(s)
  • (c) Complications 5 mark(s)
Q215 marksEssays

Answer

(a) Clinical features

  • Incubation period of 1–6 months
  • Acute hepatitis: Prodromal phase (fatigue, anorexia, nausea, low-grade fever), followed by icteric phase (jaundice, dark urine, pale stools, right upper quadrant discomfort, hepatomegaly) — most adult infections resolve completely
  • Chronic hepatitis: Develops in a proportion of infected individuals (higher risk with perinatal/early childhood infection), often asymptomatic or with non-specific fatigue, may progress silently to cirrhosis over years
  • Fulminant hepatitis: Rare, severe acute liver failure with encephalopathy and coagulopathy
  • Extrahepatic manifestations: polyarteritis nodosa, membranous glomerulonephritis (immune complex-mediated)

(b) Gross and microscopic changes in liver

Gross

  • Acute hepatitis: liver may be normal-sized or slightly enlarged, red-tan, soft
  • Chronic hepatitis with cirrhosis: shrunken, nodular, firm liver with a diffusely irregular surface

Microscopic

  • Acute hepatitis: Diffuse hepatocyte swelling (ballooning degeneration), individual cell necrosis with acidophil (Councilman) bodies, mixed portal and lobular inflammatory infiltrate, Kupffer cell hyperplasia, cholestasis
  • Chronic hepatitis: Portal/periportal inflammation with interface hepatitis (piecemeal necrosis), progressive fibrosis (periportal → bridging → cirrhosis), ground-glass hepatocytes (finely granular eosinophilic cytoplasm from HBsAg accumulation)

(c) Complications

  • Chronic hepatitis and progression to cirrhosis
  • Hepatocellular carcinoma (markedly increased risk with chronic HBV infection, can occur even without cirrhosis due to direct oncogenic viral integration)
  • Fulminant hepatic failure (rare, acute)
  • Extrahepatic immune complex-mediated disease (polyarteritis nodosa, membranous glomerulonephritis)
  • Superinfection with Hepatitis D virus (worsens prognosis significantly)

Other Years Asked


Revise MBBS
Preview